GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GT Biopharma Inc (FRA:OXIA) » Definitions » Interest Paid

GT Biopharma (FRA:OXIA) Interest Paid


View and export this data going back to 2005. Start your Free Trial

What is GT Biopharma Interest Paid?

Interest Paid only applicable to companies reporting Cash Flow from Operations in direct method.


GT Biopharma (FRA:OXIA) Business Description

Traded in Other Exchanges
Address
8000 Marina Boulevard, Suite 100, Brisbane, CA, USA, 94005
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.